Abstract:Genetic toxicity testing assesses the potential of compounds to cause DNA damage. There are many genetic toxicology screening assays designed to assess the DNA damaging potential of chemicals in early drug development aiding the identification of promising drugs that have low-risk potential for causing genetic damage contributing to cancer risk in humans. Despite this, in vitro tests generate a high number of misleading positives, the consequences of which can lead to unnecessary animal testing and/or the abandonment of promising drug candidates. Understanding chemical Mode of Action (MoA) is vital to identifying the true genotoxic potential of substances and, therefore, the risk translation into the clinic. Here we demonstrate a simple, robust protocol for staining fixed, human-lymphoblast p53 proficient TK6 cells with antibodies against ɣH2AX, p53 and pH3S28 along with DRAQ5TM DNA staining that enables analysis of un-lysed cells via microscopy approaches such as imaging flow cytometry. Here, we used the Cytek® Amnis® ImageStream®X Mk II which provides a high-throughput acquisition platform with the sensitivity of flow cytometry and spatial morphological information associated with microscopy. Using the ImageStream manufacturer's software (IDEAS® 6.2), a masking strategy was developed to automatically detect and quantify micronucleus events (MN) and characterise biomarker populations. The gating strategy developed enables the generation of a template capable of automatically batch processing data files quantifying cell-cycle, MN, ɣH2AX, p53 and pH3 populations simultaneously. In this way, we demonstrate how a multiplex system enables DNA damage assessment alongside MN identification using un-lysed cells on the imaging flow cytometry platform. As a proof-of-concept, we use the tool chemicals carbendazim and methyl methanesulphonate (MMS) to demonstrate the assay's ability to correctly identify clastogenic or aneugenic MoAs using the biomarker profiles established.

Automated detection of cytokinesis-blocked micronuclei using fuzzy c-means algorithm and morphological features

Review of the origin, fate, and influencing factors of cytokinesis-block micronucleus

Mutual-Complementing Framework for Nuclei Detection and Segmentation in Pathology Image

Cytokinesis-Block Micronucleus Cytome Assay Evolution into a More Comprehensive Method to Measure Chromosomal Instability

Inter-laboratory automation of the in vitro micronucleus assay using imaging flow cytometry and deep learning

A Fuzzy Segmentation Method to Learn Classification of Mitosis

A multi-biomarker micronucleus assay using imaging flow cytometry

micronuclAI: Automated quantification of micronuclei for assessment of chromosomal instability.

An Automated, Single Cell Quantitative Imaging Microscopy Approach to Assess Micronucleus Formation, Genotoxicity and Chromosome Instability

Research Progress of Micronucleus Visualization Analysis and Artificial Intelligence Detection Strategy

The Micronucleus Assay on Cryopreserved Whole Blood

Application of image-recognition techniques to automated micronucleus detection in the in vitro micronucleus assay

Multiparameter imaging flow cytometry-based cytokinesis-block micronucleus assay: Reduction of culture time and blood volume for improved efficiency

Image-based identification and isolation of micronucleated cells to dissect cellular consequences

Deep Learning based Automatic Detection of Dicentric Chromosome

Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells.

AcNet: Aggregated channels network for automated mitosis detection

Development of a novel flow cytometry‐based approach for reticulocytes micronucleus test in rat peripheral blood

Automated Triage Radiation Biodosimetry: Integrating Imaging Flow Cytometry with High-Throughput Robotics to Perform the Cytokinesis-Block Micronucleus Assay

An Automated Image Cytometry System for Monitoring DNA Ploidy and Other Cell Features of Radiotherapy and Chemotherapy Patients.

Supervision Performance of the Digital Cell Morphology Analyzer MC-100i in a Multicenter Study in Tertiary Hospitals in China